Skip to main content
  •   Home
  •   Download
  •   Manual
  •   Contact

Natural Product (NP) Details

General Information of the NP (ID: NP1489)
Name
Tropisetron
Synonyms
tropisetron; 89565-68-4; Tropisetronum; Tropisteron; [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 1H-indole-3-carboxylate; UNII-6I819NIK1W; Novaban; ICS 205930; (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 1H-indole-3-carboxylate; Navoban (TN); ICF 205-930; CHEMBL56564; beta-Tropisetron; 6I819NIK1W; CHEBI:32269; Tropisetron (INN); DSSTox_CID_24137; DSSTox_RID_80108; DSSTox_GSID_44137; 1alphaH,5alphaH-Tropan-3alpha-yl indole-3-carboxylate; 1H-indole-3-carboxylic acid [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester; TKT; Lopac-T-104; CAS-89565-68-4; Tropisetron [INN:BAN]; ICS-205930; Tropisetronum [INN-Latin]; NCGC00015984-03; ICS-205-930; SCHEMBL18297; SCHEMBL18298; SCHEMBL18299; GTPL260; ics205-930; SCHEMBL3953452; CHEMBL1289230; DTXSID2044137; SCHEMBL13287285; CHEBI:94647; HMS2090D16; HMS3886M10; HY-B0072; Tox21_110272; BDBM50108392; PDSP1_000776; PDSP2_000764; s5538; ZINC18130447; AKOS015969677; Tox21_110272_1; ZINC100019233; ZINC100023360; CCG-267308; CS-1146; DB11699; 1H-Indole-3-carboxylic acid, 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, endo-; NCGC00015984-01; NCGC00015984-04; NCGC00161414-01; NCGC00161414-03; NCGC00390718-01; H833; C13666; D02130; Q29428; W-5128; AB00698553-07; AB00698553-09; 565T684; BRD-K50866992-003-09-5; BRD-K50866992-003-10-3; Q27166461; 1H-Indole-3-carboxylic acid (1R,5S)-8-methyl-8-azabicyclo[3.2.1]octane-3-yl ester
    Click to Show/Hide
Species Origin Homo sapiens ...     Click to Show/Hide
Homo sapiens
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
Disease Pain [ICD-11: MG30-MG3Z] Approved [1]
Structure
Click to Download Mol
2D MOL

3D MOL

    Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product
Formula
C17H20N2O2
PubChem CID
656665
Canonical SMILES
CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43
InChI
1S/C17H20N2O2/c1-19-11-6-7-12(19)9-13(8-11)21-17(20)15-10-18-16-5-3-2-4-14(15)16/h2-5,10-13,18H,6-9H2,1H3/t11-,12+,13?
InChIKey
ZNRGQMMCGHDTEI-FUNVUKJBSA-N
CAS Number
CAS 89565-68-4
ChEBI ID
CHEBI:32269
TTD Drug ID
D0K0KH
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally
    α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP
          Fluvoxamine      Depression     Click to Show/Hide the Molecular Data of This Drug
                 Achieving Therapeutic Synergy     Click to Show/Hide
                    Representative Experiment Reporting the Effect of This Combination [2]
                    Detail(s)  Combination Info  click to show the detail info of this combination
                    Biological
                    Regulation
Down-regulation 5-HT content
                    In-vivo Model Clinical Trial
                    Experimental
                    Result(s)
This trial showed a significant efficacy for tropisetron over placebo in treatment of obsessive-compulsive disorder symptoms when added to fluvoxamine.
Target and Pathway
Target(s) Serotonin receptor 3A (HTR3A)  Molecule Info  [3]
KEGG Pathway Serotonergic synapse Click to Show/Hide
NetPath Pathway IL2 Signaling Pathway Click to Show/Hide
Panther Pathway 5HT3 type receptor mediated signaling pathway Click to Show/Hide
Reactome Ligand-gated ion channel transport Click to Show/Hide
WikiPathways SIDS Susceptibility Pathways Click to Show/Hide
2 Iron uptake and transport
References
Reference 1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 260).
Reference 2 Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial. J Psychopharmacol. 2019 Nov;33(11):1407-1414.
Reference 3 Emerging therapies for fibromyalgia. Expert Opin Emerg Drugs. 2008 Mar;13(1):53-62.
 Download Picture         KEGG Link      
Cite NPCDR
Visitor Map
Correspondence

X. N. Sun, Y. T. Zhang, Y. Zhou, X. C. Lian, L. L. Yan, T. Pan, T. Jin, H. Xie, Z. M. Liang, W. Q. Qiu, J. X. Wang, Z. R. Li, F. Zhu*, X. B. Sui*. NPCDR: natural product-based drug combination and its disease-specific molecular regulation. Nucleic Acids Research. 50(D1): 1324-1333 (2020). PMID: 34664659

Prof. Feng ZHU  (zhufeng@zju.edu.cn)

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China


Prof. Xinbing SUI  (hzzju@hznu.edu.cn)

School of Pharmacy and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China